Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1463
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia ; volume:119 ; number:7 ; day:19 ; month:4 ; year:2012 ; pages:805-813 ; date:7.2012
Journal of neural transmission ; 119, Heft 7 (19.4.2012), 805-813, 7.2012
- Urheber
-
Bibl, Mirko
- Beteiligte Personen und Organisationen
-
Gallus, Marion
Welge, Volker
Esselmann, Hermann
Wolf, Stefanie
Rüther, Eckart
Wiltfang, Jens
SpringerLink (Online service)
- DOI
-
10.1007/s00702-012-0801-3
- URN
-
urn:nbn:de:101:1-2018101910585987394995
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bibl, Mirko
- Gallus, Marion
- Welge, Volker
- Esselmann, Hermann
- Wolf, Stefanie
- Rüther, Eckart
- Wiltfang, Jens
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Eisregen, [...]. [Partitur]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Eisregen, [...]. [Partitur]
Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
Computergestütztes Screening kognitiver Beeinträchtigungen - Ergebnisse einer Validierungsstudie zum Programm „Kopfsache Interaktiv”
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease
Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia
Use of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany
Presenilins in Alzheimer’s disease and frontotemporal dementia
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease
Veränderungen der Immunzellzusammensetzung im Liquor cerebrospinalis bei Demenzen
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis
Eisregen, [...]. [Partitur]
Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
Computergestütztes Screening kognitiver Beeinträchtigungen - Ergebnisse einer Validierungsstudie zum Programm „Kopfsache Interaktiv”
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease
Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia
Use of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany
Presenilins in Alzheimer’s disease and frontotemporal dementia
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease
Veränderungen der Immunzellzusammensetzung im Liquor cerebrospinalis bei Demenzen
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis
Eisregen, [...]. [Partitur]
Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
Computergestütztes Screening kognitiver Beeinträchtigungen - Ergebnisse einer Validierungsstudie zum Programm „Kopfsache Interaktiv”
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease
Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia
Use of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany
Presenilins in Alzheimer’s disease and frontotemporal dementia
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease
Veränderungen der Immunzellzusammensetzung im Liquor cerebrospinalis bei Demenzen